Two drugs firms have been accused by the competition watchdog of signing “illegal agreements” that resulted in the cost of life-saving hydrocortisone tablets sold to the NHS remaining high.
Source: Sky Business News
Two drugs firms have been accused by the competition watchdog of signing “illegal agreements” that resulted in the cost of life-saving hydrocortisone tablets sold to the NHS remaining high.
Source: Sky Business News